New Zealand - English - Medsafe (Medicines Safety Authority)

dentsply sirona (nz) limited - adrenaline acid tartrate 18.2 µg/ml equivalent to adrenaline 10 micrograms/ml; articaine hydrochloride 40 mg/ml - solution for injection - active: adrenaline acid tartrate 18.2 µg/ml equivalent to adrenaline 10 micrograms/ml articaine hydrochloride 40 mg/ml excipient: hydrochloric acid sodium chloride sodium hydroxide sodium metabisulfite water for injection - indicated for local or regional anaesthesia for both simple and complex dental procedures in adults, adolescents and children 4 years of age and older. indicated only for dental procedures.

New Zealand - English - Medsafe (Medicines Safety Authority)

dentsply sirona (nz) limited - lidocaine 25 mg/g;  ; prilocaine 25 mg/g - oral gel - active: lidocaine 25 mg/g   prilocaine 25 mg/g excipient: hydrochloric acid poloxamer 188 poloxamer 407 purified water

New Zealand - English - Medsafe (Medicines Safety Authority)

dentsply sirona (nz) limited - adrenaline acid tartrate 0.0227mg equivalent to 12.5 µg adrenaline;  ; lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous - solution for injection - active: adrenaline acid tartrate 0.0227mg equivalent to 12.5 µg adrenaline   lidocaine hydrochloride monohydrate 21.3mg equivalent to 20 mg lignocaine hydrochloride anhydrous excipient: hydrochloric acid sodium chloride sodium hydroxide sodium metabisulfite water for injection - the product is indicated for the production of local nerve anaesthesia in routine dental procedures and oral surgery by means of infiltration and nerve block techniques. lidocaine solutions with adrenaline are recommended for oral surgery requiring prolonged duration of anaesthesia and haemostasis.

New Zealand - English - Medsafe (Medicines Safety Authority)

dentsply sirona (nz) limited - felypressin 0.54 µg/ml; prilocaine hydrochloride 3% (30mg/ml.);   - solution for injection - active: felypressin 0.54 µg/ml prilocaine hydrochloride 3% (30mg/ml.)   excipient: hydrochloric acid sodium chloride sodium hydroxide water for injection - infiltration anaesthesia in dentistry, where there is no need for profound ischaemia in the injected area.

Australia - English - Department of Health (Therapeutic Goods Administration)

dentsply sirona pty ltd - articaine hydrochloride, quantity: 40 mg/ml; adrenaline (epinephrine) acid tartrate, quantity: 18.2 microgram/ml (equivalent: adrenaline (epinephrine), qty 10 microgram/ml) - injection, solution - excipient ingredients: sodium chloride; sodium metabisulfite; sodium hydroxide; hydrochloric acid; water for injections - 4 percent articadent dental with adrenaline 1:100,000 is indicated for local or regional anaesthesia for both simple and complex dental procedures in adults, adolescents and children 4 years of age and older. 4 percent articadent dental with adrenaline 1:100,000 is indicated only for dental procedures.

Australia - English - Department of Health (Therapeutic Goods Administration)

dentsply sirona pty ltd - prilocaine, quantity: 42.5 mg; lidocaine, quantity: 42.5 mg - gel - excipient ingredients: poloxamer; hydrochloric acid; purified water - for use in adults for localised anaesthesia in periodontal pockets for probing, scaling and/or root planing.

Singapore - English - HSA (Health Sciences Authority)

dentsply sirona singapore pte ltd - dental - intended for both one-and two-stage surgical procedures in the following situations and with the clinical protocols: replacing missing teeth in single or multiple unit applications in the mandible or maxilla -immediate placement in extraction sites and in situations with partially or completely healed alveolar ridge -especially indicated for use in soft bone applications where implants with other implant surface treatments may be less effective -immediate & early loading for all indications except in single tooth situations on implant shorter than 8mm or in soft bone (type iv)where implant stability may be difficult to obtain & immediate loading may not be appropriate. intended use for osseospeed ev3.0s is limited to placement of maxillary lateral incisors & mandibular incisors. osseospeed profile ev4.2&4.8 are to be used only together with profile ev restorative components,implant driver profile ev, radiographic implant guides profile ev & non-indexed prosthetic components within astra tech implant system ev.

Australia - English - Department of Health (Therapeutic Goods Administration)

dentsply sirona pty ltd - prilocaine hydrochloride, quantity: 30 mg/ml; felypressin, quantity: 0.54 microgram/ml - injection, solution - excipient ingredients: sodium chloride; water for injections; hydrochloric acid; sodium hydroxide - citanest is indicated for the production of local anaesthesia in routine dental procedures and oral surgery by means of infiltration and nerve block techniques.

Australia - English - Department of Health (Therapeutic Goods Administration)

dentsply sirona pty ltd - prilocaine hydrochloride, quantity: 30 mg/ml; felypressin, quantity: 0.54 microgram/ml - injection, solution - excipient ingredients: sodium chloride; water for injections; hydrochloric acid; sodium hydroxide - indications as at 23 july 2003 : citanest is indicated for the production of local anaesthesia in routine dental procedures and oral surgery by means of infiltration and nerve block tecniques.

Singapore - English - HSA (Health Sciences Authority)

dentsply sirona singapore pte ltd - dental - intended to be used in conjunction with astra tech implant system™ implants in fully edentolous or partially edentolous maxillary and / or mandibular arches to provide support for crowns, bridges or overdentures. uniabutments are used in partially dentate and totally edentulous situations to support screw-retained restorations and overdentures. the 45° uniabutment is recommended when the interocclusal space is limited, and in nonparallel situations when the inter-implant inclination exceeds 40°.